Hungary started to administer the Russain-developed Sputnik V COVID-19 vaccines recently while the EU did not authorize it yet (see e.g. https://www.euronews.com/2021/02/20/sputnik-v-why-hasn-t-the-eu-approved-russia-s-covid-vaccine-yet). According to the article, "The EMA insists that Sputnik V has not even started the continuous review phase yet", while "the Russian authorities "filed an application for registration" on January 19.". It looks like at least there's a serious miscommunication here between the parties. I'd guess it can't be that hard to start this application (even if it's technically complicated, a few phone calls for tech help could solve the issue). Why is there no progress made on this issue? I mean the EU must be motivated to buy some more vaccines as only a tiny percentage of the population is vaccinated yet. The producer of the Sputnik vaccine should be also motivated to sell its ware (and sell before the market gets saturated).
In a Feb 10 news release EMA disagrees:
The European Medicines Agency has to date not received an application for a rolling review or a marketing authorisation for the vaccine developed by the Gamaleya National Centre of Epidemiology and Microbiology in Russia, the Sputnik V vaccine (Gam-COVID-Vac), despite reports stating the opposite.
As of Feb 11, Russia has even lower Covid-19 vaccination than the EU. So why would they be in a hurry to export to the EU, publicity stunts (like those with Hungary) aside? (Keep in mind that Hungary is very small market compared to the whole of the EU.)